GEORGIA: Positive Impact Adds HIV Testing, Substance Abuse Program CDC Daily UpdateImportant note: Information in this article was accurate in 2008. The state of the art may have changed since the publication date.

Click here to return to CDC Daily Update main menu





DonateNow




GEORGIA: Positive Impact Adds HIV Testing, Substance Abuse Program

Southern Voice (Atlanta) (12.05.08) - Monday, December 15, 2008
Laura Douglas-Brown


On Dec. 1, Positive Impact learned it was awarded a CDC grant to run the Counseling, Testing & Referral Center (CTRC). The testing program's previous operator, AIDS Survival Project, said it will close at the end of the year. ASP and Positive Impact share the building at 139 Ralph McGill Blvd., and the program will continue operations without disruption.

"If we had to close, it would have been difficult for our clients to find other locations to get tested," said Kevin English, who led the testing program under ASP and who will remain in the position with Positive Impact. CTRC is centrally located in downtown Atlanta and is accessible by mass transportation, he noted.

CTRC is funded through the end of June 2010. About 200 people on average seek testing each month at the center, and about 3- 5 percent test HIV-positive - a much higher rate than at public health departments, said English.

Positive Impact, which offers mental health services to people with HIV and their partners, had earlier announced it is also expanding services to cover substance abuse-related support groups and counseling. About one-third of Positive Impact clients are also dealing with substance dependence issues, so the program was a natural extension, said Gwen Davies, the agency's clinical director. This will also help fill the void left after Our Common Welfare closed earlier this year.

"The community needed these programs, the clients needed these programs, so we couldn't just let them go," said Paul Plate, Positive Impact's executive director.
081215
AD082346


Copyright © 2008 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Elton John AIDS Foundation, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.

Always watch for outdated information. This article first appeared in 2008. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2008. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.

.